{
    "nctId": "NCT05519397",
    "briefTitle": "Evaluation of the Role of Immune Checkpoints in Response to Breast Cancer Neoadjuvant Therapy",
    "officialTitle": "Evaluation of the Role of Immune Checkpoints in Response to Breast Cancer Neoadjuvant",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 56,
    "primaryOutcomeMeasure": "Immune checkpoints",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Locally advanced Breast Cancer patients who will receive neoadjuvant therapy\n\nExclusion Criteria:\n\n* Known immunodeficiency\n* Having a primary malignancy other than breast cancer,\n* Pregnancy,\n* Patients who refused to participate in the study",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}